Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Cellular Biochemistry|August 10, 2005
Prospects: histone deacetylase inhibitorsMilos Dokmanovic, Paul A Marks
Expert Opinion on Investigational Drugs|November 26, 2005
Histone deacetylase inhibitors: discovery and development as anticancer agentsPaul A Marks, Milos Dokmanovic
Molecular Cancer Research : MCR|October 24, 2007
Histone deacetylase inhibitors: overview and perspectivesMilos Dokmanovic, Cathy Clarke, Paul A Marks
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2006
Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitorWeisheng Xu, Lang Ngo, Gisela Perez, et al.
Molecular Cancer Therapeutics|September 19, 2007
Histone deacetylase inhibitors selectively suppress expression of HDAC7Milos Dokmanovic, Gisela Perez, Weisheng Xu, et al.
Advances in Clinical Chemistry|August 2, 2015
Monitoring Trastuzumab Resistance and Cardiotoxicity: A Tale of Personalized MedicineMilos Dokmanovic, Wen Jin Wu
Journal of Cellular Biochemistry|December 4, 2002
Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoidsIgor B Roninson, Milos Dokmanovic
Antibody Therapeutics|May 3, 2021
Mechanisms contributing to ado-trastuzumab emtansine-induced toxicities: a gateway to better understanding of ADC-associated toxicitiesYukinori Endo, Nishant Mohan, Milos Dokmanovic, et al.
Antibody Therapeutics|September 15, 2018
Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiersNishant Mohan, Jiangsong Jiang, Milos Dokmanovic, et al.
Cancer Research|June 17, 2010
pp60c-Src phosphorylates and activates vacuolar protein sorting 34 to mediate cellular transformationDianne S Hirsch, Yi Shen, Milos Dokmanovic, et al.
Pageof 7